Universal Influenza Vaccine Technology Landscape

The Landscape is a database that compiles and summarizes publicly available information on the global R&D pipeline of universal, broadly protective, and next-generation influenza vaccine candidates, as defined in the Influenza Vaccines R&D Roadmap (IVR). Vaccine candidates profiled in the Landscape are designed to provide broader and more durable protection against seasonal and pandemic influenza, compared with current strain-specific influenza vaccines. 

CIDRAP initiated development of the Landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development (2019-2024) and currently receives support from the Collaborative Influenza Vaccine Innovation Centers (CIVICs), US National Institute of Allergy and Infectious Diseases (NIAID).

Provide Feedback

Learn More

Database last updated on Dec 4, 2024

Tracker

Vaccine Candidates 230 Vaccine Candidates
Vaccine in clinical trials 40 Vaccines in Clinical Trials
COVID+Flu Vaccine Candidates 4 COVID+Flu Vaccine Candidates
Developers 170 Developers
Platforms 6 Platforms
Preclinical 190
Phase 1 17
Phase 2 15
Phase 3 8
Approved 0

Database

Previous Next
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Platform

Influenza virus-based

16
Vaccines in
Preclinical
2
Vaccines in
Phase 1
3
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Nucleic acid-based

34
Vaccines in
Preclinical
6
Vaccines in
Phase 1
5
Vaccines in
Phase 2
4
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Non-VLP nanoparticles

44
Vaccines in
Preclinical
4
Vaccines in
Phase 1
1
Vaccines in
Phase 2
2
Vaccines in
Phase 3
0
Vaccines in
Approved